Cite
HARVARD Citation
Okamoto, T. et al. (n.d.). Anti-B16 melanoma effects of a STAT3 inhibitor (rR9-GRIM19) are strongly enhanced by co-treatment with recombinant interferons. Journal of dermatological science. 84 (1), pp. e84-e85. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Okamoto, T. et al. (n.d.). Anti-B16 melanoma effects of a STAT3 inhibitor (rR9-GRIM19) are strongly enhanced by co-treatment with recombinant interferons. Journal of dermatological science. 84 (1), pp. e84-e85. [Online].